Literature DB >> 22280997

Galactomannan testing might be useful for early diagnosis of fusariosis.

Małgorzata Mikulska1, Elisa Furfaro, Valerio Del Bono, Francesca Gualandi, Anna Maria Raiola, Maria Pia Molinari, Paola Gritti, Maurizio Sanguinetti, Brunella Posteraro, Andrea Bacigalupo, Claudio Viscoli.   

Abstract

Galactomannan (GM) is used to diagnose aspergillosis. We present a case of a hematopoietic stem cell transplantation recipient with fusariosis who received early antifungal treatment based on GM positivity. Additionally, 3 Fusarium isolates tested positive for GM. Fusarium is another mold containing GM. GM might be useful for diagnosing fusariosis in high-risk patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22280997     DOI： 10.1016/j.diagmicrobio.2011.12.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  13 in total

1.  Galactomannan testing for early diagnosis of Exserohilum rostratum infection.

Authors:  Maya Korem; Itzhack Polacheck; Ayelet Michael-Gayego; Jacob Strahilevitz
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

Review 2.  Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.

Authors:  Laura L Kovanda; Amit V Desai; William W Hope
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-08       Impact factor: 2.745

Review 3.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

4.  Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Authors:  Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

5.  Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.

Authors:  Marcio Nucci; Fabianne Carlesse; Paola Cappellano; Andrea G Varon; Adriana Seber; Marcia Garnica; Simone A Nouér; Arnaldo L Colombo
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis.

Authors:  Seven Uludokumacı; Ilker İnanç Balkan; Bilgül Mete; Reşat Ozaras; Neşe Saltoğlu; Teoman Soysal
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

7.  Development and evaluation of enzyme-linked immunosorbent assay of nucleic acid sequence-based amplification for diagnosis of invasive aspergillosis.

Authors:  Li Du; Yun Xia; Yunyan He; Qingquan Pu; Ruoyi Hua; Wenyao Wu
Journal:  AMB Express       Date:  2016-10-06       Impact factor: 3.298

8.  Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan.

Authors:  Ema Paulovičová; Lucia Paulovičová; Martin Hrubiško; Vadim B Krylov; Dmitry A Argunov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

Review 9.  Fusarium infection: report of 26 cases and review of 97 cases from the literature.

Authors:  Maged Muhammed; Theodora Anagnostou; Athanasios Desalermos; Themistoklis K Kourkoumpetis; Herman A Carneiro; Justin Glavis-Bloom; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

Review 10.  Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Authors:  Richard C Barton
Journal:  Scientifica (Cairo)       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.